摘要
炎症性肠病（IBD）是一组主要累及消化道的自身免疫性疾病，调节和抑制免疫反应是治疗的主要内容。目前治疗IBD的药物主要包括氨基水杨酸类药物、糖皮质激素、免疫抑制剂和生物制剂，为评估疗效和监测药物不良反应，治疗中需定期监测相关实验室指标。
Inflammatory bowel disease （IBD） is a group of autoimmune diseases mainly involving the digestive tract. Regulating and inhibiting immune response is the main content of drug therapy. Currently, drugs for IBD mainly include aminosalicylic acid, glucocorticoids, immunosuppressive agents and biological agents . To evaluate efficacy and monitor drug adverse reaction, laboratory examinations should be performed regularly during treatment of IBD.（Chin J Lab Med, 2018, 41： 781-783）
作者
蔡洁珠
陈宁
Cai Jiezhu;Chen Ning(Department of Gastroenterology,People＇s Hospital of Peking University,Beijing 100044,China)
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2018年第10期781-783,共3页
Chinese Journal of Laboratory Medicine
关键词
炎性肠疾病
药物监测
感染控制
Inflammatory bowel disease
Drug monitoring
Infection control
